Direct dosing APIs during R&D studies can reduce the overall testing time of a drug candidate by allowing for a greater throughput of compounds through the R&D department.
David Edwards
Advertisement
David Edwards is Director of Pharmaceutical Technology at Capsugel.
Articles by David Edwards
Advertisement
Latest Updated Articles
Improving R&D with API microdosingPublished: September 1st 2011 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Sustainability and Stability in Excipients
2
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
3
Turning Real-World Data into Actionable Drug Development Insights With AI
4
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
5
